Clinical guide
Opioid Use Disorder: Symptoms, Overdose Risk, and Treatment
Opioid use disorder causes impaired control over opioid use despite harm. Learn its symptoms, overdose risks, withdrawal, diagnosis, and treatment.
By Paul James Roeser·Reviewed by Dr. Michael Olla, MD·Last reviewed August 22, 2026·7 min read
Published ·Updated
Opioid use disorder (OUD) is a substance use disorder that causes impaired control over opioid use, continued use despite harm, and clinically significant distress or disability. The condition can involve prescription pain medication, heroin, fentanyl, or another opioid. A person's route of exposure does not determine whether the disorder is real or whether treatment is warranted.
Opioids relieve pain and can produce sedation or euphoria, but they also suppress breathing. Repeated exposure can produce tolerance, physical dependence, craving, and compulsive use. These effects overlap, yet they describe different clinical problems and require individual assessment.
What is opioid use disorder?
Opioid use disorder is a medical condition in which a pattern of opioid use causes impaired control, harmful consequences, or major disruption in daily life. Clinicians diagnose the disorder from the pattern and severity of symptoms rather than from the presence of one drug, one dose, or one withdrawal episode.
Diagnostic features can include taking more opioids than intended, unsuccessful efforts to reduce use, craving, hazardous use, neglected responsibilities, continued use despite physical or interpersonal harm, tolerance, and withdrawal. Tolerance and withdrawal do not count toward an OUD diagnosis when they occur solely during appropriate medical treatment, so a clinician must interpret them in context.
Clinical perspective
Opioid addiction rewires the reward system and the pain system at the same time, which is part of why relapse rates are so high without medication support. MAT shouldn't be treated as a bridge to abstinence-only recovery — for a lot of people, it's the treatment, full stop, for as long as it needs to be. That reframe alone changes how a lot of families think about what recovery is supposed to look like.

How do opioid use, physical dependence, and addiction differ?
Opioid use describes exposure, physical dependence describes adaptation, and addiction describes impaired control despite harm. A patient can become physically dependent while taking an opioid exactly as prescribed, and abrupt discontinuation can then cause withdrawal without proving addiction.
Misuse means taking an opioid in a way, amount, or purpose that a clinician did not direct. Opioid addiction is the severe, compulsive end of opioid use disorder. Clear terminology helps clinicians protect pain treatment, manage withdrawal safely, and address harmful use without stigma.
Which drugs are opioids?
Opioids include natural opiates, semi-synthetic medicines, fully synthetic medicines, and illegally manufactured drugs that activate opioid receptors. Clinical classification places morphine and codeine among natural opiates; oxycodone, hydrocodone, heroin, and buprenorphine among semi-synthetic opioids; and methadone, tramadol, and fentanyl among synthetic opioids.
Medical purpose does not make every opioid equally risky, and illicit status does not describe pharmacology. Prescribed fentanyl has tightly controlled medical uses, while illicitly manufactured fentanyl creates unpredictable exposure through powders and counterfeit pills.
What signs and symptoms indicate opioid use disorder?
Opioid use disorder produces behavioral signs, physical adaptations, and functional consequences that persist despite attempts to control use. Common warning signs include escalating use, early refill requests, secretive behavior, spending substantial time obtaining or recovering from opioids, and withdrawing from work, school, family, or usual activities.
- Impaired control: using more or longer than intended, craving opioids, or repeatedly failing to cut down.
- Functional harm: missing responsibilities, abandoning activities, or continuing use despite relationship problems.
- Hazardous use: using while driving, combining opioids with sedatives, or returning to a dose after tolerance has fallen.
- Physical effects: drowsiness, constipation, nausea, pinpoint pupils, tolerance, or withdrawal between doses.
These signs support clinical evaluation, but no checklist can identify the substance, determine severity, or select a treatment level by itself.

How do opioids affect the brain and body?
Opioids activate receptors that reduce pain, alter reward learning, slow gastrointestinal movement, and suppress the brain's drive to breathe. Short-term effects can include pain relief, drowsiness, nausea, constipation, slowed reaction time, and euphoria.
Repeated exposure can make the body less responsive to the same dose and can produce withdrawal when use stops. Injection adds risks from contaminated equipment, including skin infection, endocarditis, hepatitis, and HIV. Clinical care must also account for alcohol, benzodiazepines, and other sedatives because these combinations compound respiratory depression and raise overdose risk.

Who is at increased risk for opioid use disorder or overdose?
Prior overdose, a history of substance use disorder, high-risk drug combinations, reduced tolerance, and an unpredictable illicit supply increase opioid-related harm. Pain, trauma, depression, anxiety, unstable housing, and limited access to care can also shape risk, but none of these factors makes addiction inevitable.
Overdose risk rises after abstinence because tolerance can fall during hospitalization, incarceration, detoxification, or a period of recovery. A return to a previously tolerated amount can then suppress breathing. Clinical assessment should examine the opioid, route, frequency, other substances, medical conditions, psychiatric symptoms, overdose history, and available support.

How common are opioid overdose deaths in the United States?
Opioids remained involved in most national drug overdose deaths reported in final 2024 mortality data. The CDC National Center for Health Statistics reported that 54,045 overdose deaths involved any opioid in 2024, including 47,735 deaths involving synthetic opioids other than methadone and 2,743 involving heroin.
Drug categories overlap because one death can involve several substances. The synthetic-opioid category includes fentanyl, fentanyl analogs, and tramadol, so it should not be presented as an exact fentanyl count. National totals guide treatment and prevention planning; they do not predict an individual's dose response or outcome.
What are the signs of an opioid overdose?
Opioid overdose causes unresponsiveness, slow or shallow breathing, choking or gurgling sounds, discolored lips or nails, and small pupils that do not react to light. This clinical emergency requires an overdose response when a person cannot be awakened or is not breathing normally, even when the substance is unknown.
Give naloxone if it is available, call 911, support breathing if trained, place a breathing person on their side, and stay until help arrives. The naloxone overdose response explains why another dose may be needed when the person does not respond or becomes very sleepy again.
The fentanyl fold describes a pronounced forward slump reported during fentanyl intoxication, but posture alone does not identify the drug or replace an overdose response when breathing or consciousness is impaired.
According to the FDA's NARCAN Drug Facts label, a responder should wait 2 to 3 minutes after the first nasal-spray dose and continue giving available doses at 2- to 3-minute intervals until the person wakes or emergency help arrives. Improvement is temporary and does not replace medical evaluation.
What does opioid withdrawal feel like?
Opioid withdrawal produces a predictable group of physical and psychological symptoms after a dependent person reduces or stops an opioid. Symptoms can include craving, anxiety, restlessness, sweating, yawning, runny nose, muscle aches, abdominal cramps, nausea, vomiting, diarrhea, and insomnia.
Withdrawal is usually not fatal by itself, but vomiting and diarrhea can cause dehydration, pregnancy and medical conditions can increase risk, and return to use after tolerance falls can cause overdose. A supervised opioid withdrawal assessment can identify the substance, expected timing, clinical risks, and appropriate medication.
How is opioid use disorder treated?
Opioid use disorder treatment combines medication, overdose prevention, behavioral care, and continuing recovery support according to clinical need. Buprenorphine, methadone, and naltrexone are FDA-approved medications for OUD. Buprenorphine and methadone reduce withdrawal and craving through opioid-receptor activity, while naltrexone blocks opioid effects after an opioid-free interval.
According to the CDC, medication treatment is associated with lower overdose and overall mortality, while detoxification without OUD medication is not recommended because it increases the risks of resumed use, overdose, and overdose death. Medication can continue for months, years, or longer when benefits persist; an arbitrary stop date is not a recovery requirement.
Behavioral therapy, peer services, family support, psychiatric care, pain treatment, housing assistance, and infectious-disease care can address needs that medication alone does not resolve. A structured opioid addiction treatment program can coordinate these services after emergency stabilization or an external medical detox referral.
How is the appropriate level of opioid treatment selected?
A clinical assessment selects treatment intensity from withdrawal risk, overdose history, medical stability, psychiatric symptoms, home support, and ability to participate safely. Some people need hospital care or medically managed withdrawal before rehabilitation, while others can begin medication and therapy in an outpatient setting.
Care should become more or less intensive as risk and functioning change. Continued opioid exposure, a lapse, or difficulty engaging does not prove that treatment has failed; it signals a need to reassess medication, dose, access barriers, co-occurring conditions, and the current level of support.
Frequently asked questions about opioid use disorder
Can prescribed opioids cause opioid use disorder?
Yes. OUD can develop during prescribed treatment, although monitored medical use does not automatically become addiction. A clinician should assess impaired control and harm without abruptly ending necessary pain care.
Is opioid dependence the same as opioid addiction?
No. Dependence is a physical adaptation that can occur with appropriate treatment. Addiction involves impaired control, compulsive use, and continued use despite harm.
Does naloxone treat opioid use disorder?
No. Naloxone reverses an opioid overdose temporarily. Buprenorphine, methadone, and naltrexone treat OUD over time, while behavioral and recovery services address additional needs.
Sources & References6ShowHide
- National Institute on Drug Abuse. Opioids — Federal overview of natural, semi-synthetic, and synthetic opioids, addiction risk, and the role of illicitly manufactured fentanyl in overdose deaths.
- CDC National Center for Health Statistics. FastStats: Drug Overdoses — Final 2024 national mortality counts for deaths involving any opioid, synthetic opioids other than methadone, and heroin.
- CDC. Opioid Use Disorder: Treating — Clinical guidance on diagnosing OUD, medications for OUD, and the risks of detoxification without medication treatment.
- SAMHSA. Treatment Options for Substance Use Disorder — Federal guidance on buprenorphine, methadone, naltrexone, behavioral care, and long-term medication treatment.
- CDC. What to Do If You Think Someone Is Overdosing — Bystander guidance on opioid overdose signs, naloxone, emergency response, positioning, and monitoring.
- FDA. NARCAN Naloxone Hydrochloride Nasal Spray Drug Facts Label — Official instructions for administering naloxone nasal spray, calling emergency services, repeat dosing, and staying with the person.